Amedisys Research And Ddevelopement To Revenue from 2010 to 2025
| AMED Stock | USD 92.20 0.16 0.17% |
Research And Ddevelopement To Revenue | First Reported 2010-12-31 | Previous Quarter 0.001529 | Current Value 0.001219 | Quarterly Volatility 0.00010381 |
Check Amedisys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amedisys' main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.6 M, Interest Expense of 32.3 M or Selling General Administrative of 829.6 M, as well as many indicators such as Price To Sales Ratio of 0.86, Dividend Yield of 3.0E-4 or PTB Ratio of 2.55. Amedisys financial statements analysis is a perfect complement when working with Amedisys Valuation or Volatility modules.
Amedisys | Research And Ddevelopement To Revenue |
Latest Amedisys' Research And Ddevelopement To Revenue Growth Pattern
Below is the plot of the Research And Ddevelopement To Revenue of Amedisys over the last few years. It is the ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services. Amedisys' Research And Ddevelopement To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amedisys' overall financial position and show how it may be relating to other accounts over time.
| Research And Ddevelopement To Revenue | 10 Years Trend |
|
Research And Ddevelopement To Revenue |
| Timeline |
Amedisys Research And Ddevelopement To Revenue Regression Statistics
| Arithmetic Mean | 0 | |
| Geometric Mean | 0 | |
| Coefficient Of Variation | 7.55 | |
| Mean Deviation | 0.00006 | |
| Median | 0 | |
| Standard Deviation | 0.0001 | |
| Sample Variance | 0.00000001 | |
| Range | 5.0E-4 | |
| R-Value | 0.29 | |
| Mean Square Error | 0.00000001 | |
| R-Squared | 0.08 | |
| Significance | 0.28 | |
| Slope | 0.00000621 | |
| Total Sum of Squares | 0.00000016 |
Amedisys Research And Ddevelopement To Revenue History
About Amedisys Financial Statements
Amedisys stakeholders use historical fundamental indicators, such as Amedisys' Research And Ddevelopement To Revenue, to determine how well the company is positioned to perform in the future. Although Amedisys investors may analyze each financial statement separately, they are all interrelated. For example, changes in Amedisys' assets and liabilities are reflected in the revenues and expenses on Amedisys' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Amedisys. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Amedisys Correlation against competitors. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.35) | Earnings Share 1.31 | Revenue Per Share | Quarterly Revenue Growth 0.048 | Return On Assets |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.